Towards Healthcare
Cardiovascular Drugs Market to Rise USD 213.36 Bn by 2034

Cardiovascular Drugs Market 2025 Future Scope with Global Demand Rise

According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as well as lipid-lowering drug innovations. North America led the market due to the high healthcare investments.

  • Last Updated: 25 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The cardiovascular drugs market stands at USD 155.53 billion in 2025 and is expected to reach USD 213.36 billion by 2034, growing at a CAGR of 3.65% from 2024 to 2034.

North America is currently leading the cardiovascular drugs market due to the high healthcare investments.

The cardiovascular drugs market includes 6 segments such as by drug class, by route of administration, by disease indication, by distribution channel, by drug type, and by region.

Key trends include growing acquisitions to boost the cardiovascular pipeline and expand the prospects in cardiometabolic disease.

The cardiovascular drugs act by regulating blood pressure, cholesterol levels, clot formation, and cardiac function.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.